To limit application of the gag clause to self-insured group health plans.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment not agreed to: Amendment SA 4011 not agreed to in Senate by Yea-Nay Vote. 11 - 89. Record Vote Number: 208.
September 17, 2018
View full timeline
Senate amendment not agreed to: Amendment SA 4011 not agreed to in Senate by Yea-Nay Vote. 11 - 89. Record Vote Number: 208.
September 17, 2018
Roll call votes on amendments in Senate: Amendment SA 4011 not agreed to in Senate by Yea-Nay Vote. 11 - 89. Record Vote Number: 208.
September 17, 2018
Senate amendment proposed (on the floor): Amendment SA 4011 proposed by Senator Alexander for Senator Lee.(consideration: CR S6179; text: CR S6179)
September 17, 2018
Amendment SA 4011 proposed by Senator Alexander for Senator Lee. (consideration: CR S6179; text: CR S6179) To limit application of the gag clause to self-insured group health plans.
September 17, 2018
Amendment SA 4011 not agreed to in Senate by Yea-Nay Vote. 11 - 89. Record Vote Number: 208.
September 17, 2018
Senate amendment submitted
September 6, 2018
Votes
1 roll call on this amendment
Text
Submitted
SA 4011. Mr. LEE submitted an amendment intended to be proposed by him to the bill S. 2554, to ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees; which was ordered to lie on the table; as follows: On page 4, strike line 2 and all that follows through line 6 on page 5 and insert the following: ``(a) In General.--A self-insured group health plan shall-- ``(1) not restrict, directly or indirectly, any pharmacy that dispenses a prescription drug to an enrollee in the plan from informing (or penalize such pharmacy for informing) an enrollee of any differential between the enrollee's out-of- pocket cost under the plan with respect to acquisition of the drug and the amount an individual would pay for acquisition of the drug without using the plan; and ``(2) ensure that any entity that provides pharmacy benefits management services under a contract with any such health plan does not, with respect to such plan, restrict, directly or indirectly, a pharmacy that dispenses a prescription drug from informing (or penalize such pharmacy for informing) an enrollee of any differential between the enrollee's out-of-pocket cost under the plan with respect to acquisition of the drug and the amount an individual would pay for acquisition of the drug without using the plan. ``(b) Definition.--For purposes of this section, the term `out-of-pocket cost', with respect to acquisition of a drug, means the amount to be paid by the enrollee under the health plan, including any cost-sharing (including any deductible, copayment, or coinsurance) and, as determined by the Secretary, any other expenditure.''. ______